Sandbox

Probando

<R output="html" iframe="width:100%;height:250px;"> prob=0.15; nmin=1; nmax=15; x=6 m <-pbinom(rep(0:x, each = nmax-nmin+1), rep(nmin:nmax,x), prob) dim(m) <- c(nmax-nmin+1,x+1) m <- t(m) colnames(m) <- format(nmin:nmax) rownames(m) <- format(0:x) outHTML(rhtml, m, title="x\n", format="f", digits=4) </R>

<R output="display" iframe="width:400px;height:400px"> pdf(rpdf, width=5, height=5) n <- 10 prob <- 0.2 x <- seq(0, n, 1) p <- dbinom(x, n, prob) param <- list(n, prob) main <- c("Binomialverteilung - Wahrscheinlichkeitsfunktion", paste (c("Stichprobenumfang n", "Wahrscheinlichkeit p"), param, sep="=")) plot(x,p, type="h", main=main) </R>

<R>1:20</R>

$\int _{-N}^{N}e^{x}\,dx$

hola [1]

1. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, and Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004 Dec;22(12):1567-72. DOI:10.1038/nbt1037 |
2. Ubhayasekera W, Muñoz IG, Vasella A, Ståhlberg J, and Mowbray SL. Structures of Phanerochaete chrysosporium Cel7D in complex with product and inhibitors. FEBS J. 2005 Apr;272(8):1952-64. DOI:10.1111/j.1742-4658.2005.04625.x |

1. 2004FMC Casajuana J, Aragonès R, Ariza F. Significado clínico de un PSA elevado FMC 2004;11(10) 604-13.
2. 2007JNCI pmid=17925534
3. 2006coc pmid=16856057
4. hhh pmid=7512779
5. 1999fampract pmid=10625141
6. 2006safr pmid=17252159
7. 2007uti pmid=17627768
8. 2007rrcr pmid=17432551
9. 2007urol1 pmid=18158030
10. 2006clev pmid=16973049
11. 2003clev pmid=15555136
12. 2001atpr pmid=11718642
13. 2004urol pmid=14972478
14. 2001urol pmid=11744475
15. 2007bmj pmid=18006968
16. 2007afp1 pmid=17708134
17. 2006bmj pmid=16690676
18. 2003bmj pmid=14512475
19. 2003afp pmid=12613733
20. 2002cmaj pmid=12197692
21. 2004aim pmid=15126260
22. 2006clch pmid=16762996
23. 2004ccc pmid=15090718
24. 2007nejm pmid=18160689
25. 2008bju pmid=17760888
26. 2007jncc pmid=17692178
27. 2007bju pmid=17594349
28. 2007cmaj pmid=17576986
29. 2007ju1 pmid=17509297
30. 2007afp pmid=17492070
31. 2007ju pmid=17499293
32. 2007clt pmid=17292541
33. 2007mcp pmid=17290734
34. 2006aeu1 pmid=17283721
35. 2007cl pmid=17258389
36. 2007p pmid=17143882
37. 2007bjui pmid=17550409
38. 2007urol pmid=17382151
39. 2005wimj pmid=15999885
40. 2004bju pmid=14678366
41. 2002can pmid=12365027
42. NICE1 Guidance for ...Outcomes in Urological The Research Evidence NICE
43. 2006oncol pmid=16601365
44. 2006bju pmid=16566811
45. 2002cpc pmid=15046699

3. Mistry K and Cable G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract. 2003 Mar-Apr;16(2):95-101. DOI:10.3122/jabfm.16.2.95 |
4. Hoffman RM, Clanon DL, Chavez M, and Peirce JC. Using multiple cutpoints for the free-to-total prostate specific antigen ratio improves the accuracy of prostate cancer detection. Prostate. 2002 Jul 1;52(2):150-8. DOI:10.1002/pros.10111 |
5. Hoffman RM, Clanon DL, Littenberg B, Frank JJ, and Peirce JC. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J Gen Intern Med. 2000 Oct;15(10):739-48. DOI:10.1046/j.1525-1497.2000.90907.x |
6. Lee R, Localio AR, Armstrong K, Malkowicz SB, Schwartz JS, and Free PSA Study Group. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology. 2006 Apr;67(4):762-8. DOI:10.1016/j.urology.2005.10.052 |
7. Erol H, Beder N, Calişkan T, Dündar M, Unsal A, and Culhaci N. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies?. Urol Int. 2006;76(1):20-6. DOI:10.1159/000089730 |

1. 2006upur pmid=16504254
2. cocaid pmid=12804407
3. 2006ijcp pmid=17109668
4. tramf tacto rectal amf
5. cks hbp